Fig. 8

Advances in the treatment of patients with lung cancer over the past 50 years. Advances in the treatment of patients with lung cancer over the past 50 years can be divided into cytotoxic chemotherapy, oncogene-targeted therapy and immunotherapy, with the most recent advances being in oncogene-targeted therapy and immunotherapy. All FDA approvals noted apply to patients with locally advanced or metastatic lung cancer